Europe Transcriptomics Market 2023-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity
- Report ID: 57506
- Date: May, 2023
- Pages: 121
- Category: Healthcare & Pharmaceuticals
Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 42 tables and 37 figures, this 121-page report “Europe Transcriptomics Market 2023-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe transcriptomics market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2023 till 2031 with 2022 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Europe transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.
Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2031 included in each section.
• Instruments
• Consumables
• Software
• Services
Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2031 included in each section.
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies
By Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2031 included in each section.
• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications
By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2023-2031 included in each section.
• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users
Geographically, the following national/local markets are fully investigated:
• Germany
• UK
• France
• Spain
• Italy
• Netherlands
• Rest of Europe (further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2023-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of Europe Market by Component 41
3.1 Market Overview by Component 41
3.2 Instruments 43
3.3 Consumables 45
3.4 Software 47
3.5 Services 49
4 Segmentation of Europe Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.3 Next-Generation Sequencing 54
4.4 Microarray 56
4.5 In-Situ Hybridization (ISH) 58
4.6 Gene Regulation Technologies 60
4.7 Other Technologies 61
5 Segmentation of Europe Market by Application 62
5.1 Market Overview by Application 62
5.2 Drug Discovery and Development 64
5.3 Diagnostics 65
5.4 Single Cell Analysis 66
5.5 Gene Expression 67
5.6 Cell Biology 68
5.7 Other Applications 69
6 Segmentation of Europe Market by End User 70
6.1 Market Overview by End User 70
6.2 Academic and Research Institutions 72
6.3 Biotechnology and Biopharmaceutical Companies 73
6.4 Contract Research Organizations (CROs) 74
6.5 Other End Users 75
7 European Market 2021-2031 by Country 76
7.1 Overview of European Market 76
7.2 Germany 79
7.3 U.K. 81
7.4 France 83
7.5 Spain 85
7.6 Italy 87
7.7 Netherlands 89
7.8 Rest of European Market 91
8 Competitive Landscape 93
8.1 Overview of Key Vendors 93
8.2 New Product Launch, Partnership, Investment, and M&A 98
8.3 Company Profiles 99
10x Genomics 99
Agilent Technologies, Inc. 101
ANGLE plc 102
Becton, Dickinson and Company (BD) 103
Bio-Rad Laboratories, Inc. 104
BioSypder, Inc. 105
Bio-Techne 106
Cytiva 107
F. Hoffmann-La Roche Ltd. 108
Fluidigm Corporation 109
GE Healthcare 110
Illumina, Inc. 111
Menarini Silicon Biosystems 112
Merck & Co., Inc. 113
NanoString 114
Pacific Biosciences of California, Inc. 115
PerkinElmer Inc. 116
Promega Corporation 117
Qiagen N. V. 118
Takara Bio Inc. 119
Thermo Fisher Scientific Inc. 120
RELATED REPORTS 121
List of Tables
List of Tables:
Table 1. Snapshot of Europe Transcriptomics Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Transcriptome Databases 28
Table 4. World Personalized Medicine Market, 2021-2031, $ bn 29
Table 5. Main Product Trends and Market Opportunities in Europe Transcriptomics Market 33
Table 6. Europe Transcriptomics Market by Component, 2021-2031, $ mn 41
Table 7. Main Instrument Products from Key Vendors 44
Table 8. Main Consumable Products from Key Vendors 46
Table 9. Main Software Products from Key Vendors 48
Table 10. Europe Transcriptomics Market by Technology, 2021-2031, $ mn 50
Table 11. Main PCR-based Transcriptomics and Key Vendors 53
Table 12. Main NGS-based Transcriptomics and Key Vendors 55
Table 13. Main Microarray-based Transcriptomics and Key Vendors 57
Table 14. Main ISH-based Transcriptomics and Key Vendors 59
Table 15. Europe Transcriptomics Market by Application, 2021-2031, $ mn 62
Table 16. Europe Transcriptomics Market by End User, 2021-2031, $ mn 70
Table 17. Europe Transcriptomics Market by Country, 2021-2031, $ mn 78
Table 18. Germany Transcriptomics Market by Component, 2021-2031, $ mn 80
Table 19. Germany Transcriptomics Market by Technology, 2021-2031, $ mn 80
Table 20. Germany Transcriptomics Market by Application, 2021-2031, $ mn 80
Table 21. U.K. Transcriptomics Market by Component, 2021-2031, $ mn 82
Table 22. U.K. Transcriptomics Market by Technology, 2021-2031, $ mn 82
Table 23. U.K. Transcriptomics Market by Application, 2021-2031, $ mn 82
Table 24. France Transcriptomics Market by Component, 2021-2031, $ mn 84
Table 25. France Transcriptomics Market by Technology, 2021-2031, $ mn 84
Table 26. France Transcriptomics Market by Application, 2021-2031, $ mn 84
Table 27. Spain Transcriptomics Market by Component, 2021-2031, $ mn 86
Table 28. Spain Transcriptomics Market by Technology, 2021-2031, $ mn 86
Table 29. Spain Transcriptomics Market by Application, 2021-2031, $ mn 86
Table 30. Italy Transcriptomics Market by Component, 2021-2031, $ mn 88
Table 31. Italy Transcriptomics Market by Technology, 2021-2031, $ mn 88
Table 32. Italy Transcriptomics Market by Application, 2021-2031, $ mn 88
Table 33. Netherlands Transcriptomics Market by Component, 2021-2031, $ mn 90
Table 34. Netherlands Transcriptomics Market by Technology, 2021-2031, $ mn 90
Table 35. Netherlands Transcriptomics Market by Application, 2021-2031, $ mn 90
Table 36. Transcriptomics Market in Rest of Europe by Country, 2021-2031, $ mn 92
Table 37. Transcriptomic Products Approved by FDA 95
Table 38. Sequencing Technology Platforms for RNA-Sequencing 96
Table 39. RNA-Sequencing De Novo Assembly Software 96
Table 40. 10x Genomics: Company Snapshot 99
Table 41. 10x Genomics: Business Segmentation 100
Table 42. 10x Genomics: Product Portfolio 100
List of Figures
List of Figures:
Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 17
Figure 4. Europe Transcriptomics Market, 2021-2031, $ mn 20
Figure 5. Impact of COVID-19 on Business 23
Figure 6. Primary Drivers and Impact Factors of Europe Transcriptomics Market 25
Figure 7. Primary Restraints and Impact Factors of Europe Transcriptomics Market 30
Figure 8. Investment Opportunity Analysis 34
Figure 9. Porter’s Fiver Forces Analysis of Europe Transcriptomics Market 37
Figure 10. Breakdown of Europe Transcriptomics Market by Component, 2021-2031, % of Revenue 42
Figure 11. Europe Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%) 42
Figure 12. Europe Transcriptomics Market by Component: Instruments, 2021-2031, $ mn 43
Figure 13. Europe Transcriptomics Market by Component: Consumables, 2021-2031, $ mn 45
Figure 14. Europe Transcriptomics Market by Component: Software, 2021-2031, $ mn 47
Figure 15. Europe Transcriptomics Market by Component: Services, 2021-2031, $ mn 49
Figure 16. Breakdown of Europe Transcriptomics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 17. Europe Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 18. Europe Transcriptomics Market by Technology: Polymerase Chain Reaction (PCR), 2021-2031, $ mn 52
Figure 19. Europe Transcriptomics Market by Technology: Next-Generation Sequencing, 2021-2031, $ mn 54
Figure 20. Europe Transcriptomics Market by Technology: Microarray, 2021-2031, $ mn 56
Figure 21. Europe Transcriptomics Market by Technology: In-Situ Hybridization (ISH), 2021-2031, $ mn 58
Figure 22. Europe Transcriptomics Market by Technology: Gene Regulation Technologies, 2021-2031, $ mn 60
Figure 23. Europe Transcriptomics Market by Technology: Other Technologies, 2021-2031, $ mn 61
Figure 24. Breakdown of Europe Transcriptomics Market by Application, 2021-2031, % of Sales Revenue 63
Figure 25. Europe Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 63
Figure 26. Europe Transcriptomics Market by Application: Drug Discovery and Development, 2021-2031, $ mn 64
Figure 27. Europe Transcriptomics Market by Application: Diagnostics, 2021-2031, $ mn 65
Figure 28. Europe Transcriptomics Market by Application: Single Cell Analysis, 2021-2031, $ mn 66
Figure 29. Europe Transcriptomics Market by Application: Gene Expression, 2021-2031, $ mn 67
Figure 30. Europe Transcriptomics Market by Application: Cell Biology, 2021-2031, $ mn 68
Figure 31. Europe Transcriptomics Market by Application: Other Applications, 2021-2031, $ mn 69
Figure 32. Breakdown of Europe Transcriptomics Market by End User, 2021-2031, % of Revenue 71
Figure 33. Europe Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 71
Figure 34. Europe Transcriptomics Market by End User: Academic and Research Institutions, 2021-2031, $ mn 72
Figure 35. Europe Transcriptomics Market by End User: Biotechnology and Biopharmaceutical Companies, 2021-2031, $ mn 73
Figure 36. Europe Transcriptomics Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 74
Figure 37. Europe Transcriptomics Market by End User: Other End Users, 2021-2031, $ mn 75
Figure 38. Breakdown of European Transcriptomics Market by Country, 2021 and 2031, % of Revenue 77
Figure 39. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 78
Figure 40. Transcriptomics Market in Germany, 2021-2031, $ mn 79
Figure 41. Transcriptomics Market in U.K., 2021-2031, $ mn 81
Figure 42. Transcriptomics Market in France, 2021-2031, $ mn 83
Figure 43. Transcriptomics Market in Spain, 2021-2031, $ mn 85
Figure 44. Transcriptomics Market in Italy, 2021-2031, $ mn 87
Figure 45. Transcriptomics Market in Netherlands, 2021-2031, $ mn 89
Figure 46. Transcriptomics Market in Rest of Europe, 2021-2031, $ mn 91
Figure 47. Growth Stage of Europe Transcriptomics Industry over the Forecast Period 93
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
